FAQ
Log In
Saturday 27th May 2017
News
 › 
 › 

Hay fever vaccine

5th January 2007

The misery of hay fever could be over for many as a new drug is launched next month.

Grazax is the first pill to offer immunity to the allergens found in grass pollens and provides a real alternative to antihistamines and nasal sprays.  Recent tests found the drug to be 83% effective. It works by exposing patients to a 15mg dose of timothy grass extract (one of the worst pollens for sufferers) which kick-starts the body’s immunity response to pollen from temperate grasses.

One in four people (about 12 million) suffers from hay fever in the UK which can have a devastating effect on quality of life.  Most sufferers are allergic to grass pollens and traditional antihistamine and steroid treatments are less than 30% effective.  It is thought that 1 in 10 hay fever sufferers could benefit from the new treatment which will be available on prescription from next month.

 

Share this page

Comments

There are no comments for this article, be the first to comment!


Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Article Information

Title: Hay fever vaccine
Author: Martine Hamilton
Article Id: 1615
Date Added: 5th Jan 2007

Sources

National Library for Health

Recent Related Articles

Brexit fears prompting EU nurses to desert the UK

Actions

Add to scrapbook
Show Comments
Add comment
Find all related articles

Tags

Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2017